Skip to main navigation

Main navigation

  • about
  • our approach
  • our pipeline
  • investors & media
  • join #onejounce
  • contact us

Main navigation

  • about
  • our approach
  • our pipeline
  • investors & media
  • join #onejounce
  • contact us
follow
contact
our media

Investors & Media

Annual Meeting

The 2022 Annual Meeting of Stockholders will be held virtually via webcast on June 24, 2022 at 9:00 am ET at www.virtualshareholdermeeting.com/JNCE2022.

Annual Meeting Materials

Title
2021 Annual Report
Title
2022 Proxy Statement

IR menu

  • Investor Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • Publications
  • Financial Information
  • Annual Meeting
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Contact IR

Pages

  • Home
  • About
  • Our Approach
  • Our Pipeline
  • Investors and Media
  • Join #OneJounce
  • Career Opportunities

Resources

  • Press Releases
  • ContactContact

Leadership

  • Management Team
  • Board of Directors
  • Company Founders

Focus

  • Pipeline Overview
  • T Cell Approach
  • Beyond T Cell

© Jounce Therapeutics, Inc. All rights reserved. | Privacy Policy | Terms of Use

Contact Us

Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge, MA 02139
Phone: (857) 259-3840
Fax: (888) 459-2940
For media inquiries, please contact:
Eric Laub
(857) 259-3853 or
elaub@jouncetx.com